Skip to main content
. 2019 Sep 10;10(52):5439–5453. doi: 10.18632/oncotarget.27145

Figure 4. Prognostic relevance of the PSA staining in prostate cancer.

Figure 4

(AD) Combination of the PSA staining intensity and apical predominance in (A) all cancers, (B) TMPRSS2: ERG negative cancers, (C) TMPRSS2: ERG positive cancers and (D) PTEN deleted cancers. (EH) Prognostic impact of the “PSA pattern score” in (E) all cancers, (F) TMPRSS2: ERG negative, (G) TMPRSS2: ERG positive and (H) PTEN deleted cancers.